14 results
8-K
EX-3.2
PNT
POINT Biopharma Global Inc.
27 Dec 23
Termination of a Material Definitive Agreement
8:54am
such reserve in the manner in which it was created.
ARTICLE VIII
RATIFICATION
Any transaction, questioned in any lawsuit on the ground of lack
8-K
EX-1.1
PNT
POINT Biopharma Global Inc.
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm
or the transactions contemplated hereby. The parties hereby irrevocably and unconditionally waive any objection to the laying of venue of any lawsuit, action … such lawsuit, action or other proceeding brought in any such court has been brought in an inconvenient forum.
17. Counterparts. This Agreement may
S-3
EX-1.2
PNT
POINT Biopharma Global Inc.
1 Jul 22
Shelf registration
4:13pm
or the transactions contemplated hereby. The parties hereby irrevocably and unconditionally waive any objection to the laying of venue of any lawsuit, action … such lawsuit, action or other proceeding brought in any such court has been brought in an inconvenient forum. The Company irrevocably designates
S-4/A
EX-10.13
dvgpbm7 c8
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4
EX-10.13
dxod o2cl6qfh62x
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
208g4
18 Mar 21
Financial Statements and Exhibits
9:08am
424B4
spqsrd1pjn8
9 Jul 20
Prospectus supplement with pricing info
4:46pm
S-1/A
jmugk 00tk1
29 Jun 20
IPO registration (amended)
12:00am
S-1
vr07 n5kjg9ehj
15 Jun 20
IPO registration
5:28pm
DRS
xt94klbvexru3a6vm4wp
14 May 20
Draft registration statement
12:00am
- Prev
- 1
- Next